The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Myositis‐specific anti‐155/140 autoantibodies target transcription intermediary factor 1 family proteins
Abstract
Objective: To identify the 140‐kd autoantigen recognized by anti‐155/140 autoantibodies that are associated with adult cancer‐associated dermatomyositis (DM) and juvenile DM and to determine the clinical relevance of anti‐155/140 antibodies in a large cohort. Methods: Sera from 456 DM patients were assessed for the presence of anti‐155/140 antibodies by immunoprecipitation using K562 cell extracts as substrate. Using immunoprecipitation and Western blotting, we then examined whether anti‐155/140–positive sera recognized transcription intermediary factor 1α (TIF‐1α), TIF‐1β, and TIF‐1γ. The clinical associations of antigen reactivity were also evaluated. Results: Anti‐155/140–positive sera reacted with 140‐kd TIF‐1α in addition to 155‐kd TIF‐1γ. Among sera from 456 DM patients, 52 were reactive with both TIF‐1α and TIF‐1γ, while another 25 were reactive with TIF‐1γ alone. Additionally, 7 were reactive with TIF‐1β. Malignancy was more frequently found in adult patients with both anti–TIF‐1α and anti–TIF‐1γ antibodies than in those with anti–TIF‐1γ antibodies alone (73% versus 50%; P < 0.05). In addition to juvenile DM patients and middle‐aged and older DM patients with high percentages of malignancy, 8 “young adult” DM patients without malignancy had these autoantibodies. Conclusion: Anti‐155/140 antibodies target TIF‐1 family proteins, TIF‐1α and TIF‐1β, in addition to TIF‐1γ. Since TIF‐1 proteins have significant roles in oncogenesis, these antibodies may be produced during misdirected antitumor immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polymyositis and Dermatomyositis: (First of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502132920706 · Cited by 5,059
Polymyositis and Dermatomyositis: (Second of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502202920807 · Cited by 2,447
Polymyositis and dermatomyositis
Dalakas, M. C., & Hohlfeld, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14368-1 · Cited by 1,416
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study
Hill, C. L., Zhang, Y., Sigurgeirsson, B., Pukkala, E., Mellemkjaer, L., Airio, A., Evans, S. R., & Felson, D. T. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03540-6 · Cited by 1,191
TRIM family proteins and their emerging roles in innate immunity
Ozato, K., Shin, D.-M., Chang, T.-H., & Morse, H. C. (2008) · Nature Reviews Immunology · doi:10.1038/nri2413 · Cited by 1,120
Polymyositis and Dermatomyositis
Hohlfeld, R., Hofmann, W. W., & Hanley, D. F. (1994) · Neurocritical Care · doi:10.1007/978-3-642-87602-8_72 · Cited by 1,083
Love, L. A., Leff, R. L., Fraser, D. D., Targoff, I. N., Dalakas, M., Plotz, P. H., & Miller, F. W. (1991) · Medicine · doi:10.1097/00005792-199111000-00002 · Cited by 969
Sato, S., Hirakata, M., Kuwana, M., Suwa, A., Inada, S., Mimori, T., Nishikawa, T., Oddis, C. V., & Ikeda, Y. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21023 · Cited by 747
Sato, S., Hoshino, K., Satoh, T., Fujita, T., Kawakami, Y., Fujita, T., & Kuwana, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24621 · Cited by 604
Fiorentino, D., Chung, L., Zwerner, J., Rosen, A., & Casciola-Rosen, L. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.09.016 · Cited by 554
p53 Antibodies in the sera of patients with various types of cancer: a review.
Soussi, T. (2000) · PubMed · Cited by 550
Sontheimer, R. D. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120621 · Cited by 486
TRIM24 links a non-canonical histone signature to breast cancer
Tsai, W.-W., Wang, Z., Yiu, T. T., Akdemir, K. C., Xia, W., Winter, S., Tsai, C.-Y., Shi, X., Schwarzer, D., Plunkett, W., et al. (2010) · Nature · doi:10.1038/nature09542 · Cited by 434
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
Casciola-Rosen, L., Nagaraju, K., Plotz, P., Wang, K., Levine, S., Gabrielson, E., Corse, A., & Rosen, A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041367 · Cited by 399
Hamaguchi, Y., Kuwana, M., Hoshino, K., Hasegawa, M., Kaji, K., Matsushita, T., Komura, K., Nakamura, M., Kodera, M., Suga, N., et al. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.52 · Cited by 333
Self-citationTrim24 targets endogenous p53 for degradation
Allton, K., Jain, A. K., Herz, H.-M., Tsai, W.-W., Jung, S. Y., Qin, J., Bergmann, A., Johnson, R. L., & Barton, M. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813177106 · Cited by 292 · cited 2×
“The depletion of TIF-1 expression in human breast cancer cells causes spontaneous apoptosis (30), and aberrant overexpression of TIF-1 in breast cancer patients is frequent and correlates with poor survival (31).”
BackgroundTripartite-motif proteins and innate immune regulation
McNab, F. W., Rajsbaum, R., Stoye, J. P., & O’Garra, A. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.10.021 · Cited by 263
MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation
Wang, C., Ivanov, A., Chen, L., Fredericks, W. J., Seto, E., Rauscher, F. J., & Chen, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600791 · Cited by 263
Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis
Hoshino, K., Muro, Y., Sugiura, K., Tomita, Y., Nakashima, R., & Mimori, T. (2010) · Rheumatology · doi:10.1093/rheumatology/keq153 · Cited by 260
Autoantibodies to a 140‐kd protein in juvenile dermatomyositis are associated with calcinosis
Gunawardena, H., Wedderburn, L. R., Chinoy, H., Betteridge, Z. E., North, J., Ollier, W. E. R., Cooper, R. G., Oddis, C. V., Ramanan, A. V., Davidson, J. E., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24547 · Cited by 234
Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis
Mammen, A. L. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05119.x · Cited by 186
Loss of Trim24 (Tif1α) gene function confers oncogenic activity to retinoic acid receptor alpha
Khetchoumian, K., Teletin, M., Tisserand, J., Mark, M. P., Herquel, B., Ignat, M., Zucman‐Rossi, J., Cammas, F. M., Lerouge, T., Thibault-Carpentier, C., et al. (2007) · Nature Genetics · doi:10.1038/ng.2007.15 · Cited by 166
Inactivation of TIF1γ Cooperates with KrasG12D to Induce Cystic Tumors of the Pancreas
Vincent, D. F., Yan, K.-P., Treilleux, I., Gay, F., Arfi, V., Kaniewski, B., Marie, J. C., Lépinasse, F., Martel, S., Goddard‐Léon, S., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000575 · Cited by 135
KAP1 Is Associated With Peritoneal Carcinomatosis in Gastric Cancer
Yokoe, T., Toiyama, Y., Okugawa, Y., Tanaka, K., Ohi, M., Inoue, Y., Mohri, Y., Miki, C., & Kusunoki, M. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0795-8 · Cited by 123
Khetchoumian, K., Teletin, M., Mark, M. P., Lerouge, T., Cerviño, M., Oulad‐Abdelghani, M., Chambon, P., & Losson, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404779200 · Cited by 85
Kijanka, G. S., Hector, S., Kay, E. W., Murray, F., Cummins, R., Murphy, D. B., MacCraith, B. D., Prehn, J. H. M., & Kenny, D. J. (2009) · Gut · doi:10.1136/gut.2009.178574 · Cited by 68
Cited by
Myositis‐specific autoantibodies: an important tool to support diagnosis of myositis
Betteridge, Z., & McHugh, N. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12451 · Cited by 1,056
Idiopathic inflammatory myopathies
Lundberg, I. E., Fujimoto, M., Vencovsky, J., Aggarwal, R., Holmqvist, M., Christopher-Stine, L., Mammen, A. L., & Miller, F. W. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00321-x · Cited by 703
Self-citationAutoantibodies in Polymyositis and Dermatomyositis
Ghirardello, A., Bassi, N., Palma, L., Borella, E., Domeneghetti, M., Punzi, L., & Doria, A. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0335-1 · Cited by 461
Satoh, M., Tanaka, S., Ceribelli, A., Calise, S. J., & Chan, E. K. L. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8510-y · Cited by 420
McHugh, N. J., & Tansley, S. L. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.56 · Cited by 390
Metadata
- Authors
- Fujimoto, M., Hamaguchi, Y., Kaji, K., Matsushita, T., Ichimura, Y., Kodera, M., Ishiguro, N., Ueda‐Hayakawa, I., Asano, Y., Ogawa, F., Fujikawa, K., Miyagi, T., Mabuchi, E., Hirose, K., Akimoto, N., Hatta, N., Tsutsui, K., Higashi, A., Igarashi, A., Seishima, M., Hasegawa, M., & Takehara, K.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2012-01-27
- Volume
- 64
- Issue
- 2
- Pages
- 513-522
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2020615609
- Cited by
- 301
- References
- 26
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.